Uncovering HIV by Looking for Indicator Conditions
Sean R. Hosein, Canadian AIDS Treatment Information Exchange; Posted Oct 13, 11:18 p.m. ET
During the early years of undiagnosed HIV infection, people can develop conditions that are generally not life threatening but have become highly associated with underlying HIV infection.
New Ideas About CD4 Cell Counts and When to Start Treatment
Sean R. Hosein, Canadian AIDS Treatment Information Exchange; Posted Oct 13, 11:15 p.m. ET
What constitutes a normal or acceptable CD4+ cell count and how do we more accurately assess the immune health of a person living with HIV?
SMAC Mimetics and HIV Latency
Richard Jefferys, Treatment Action Group; Posted Oct 13, 10:08 p.m. ET
SMAC (second mitochondrial-derived activator of caspases) mimetics are a class of compounds that have recently entered clinical trials as potential cancer treatments, but also have potential against HIV.
A Trio of Papers Provide New Insights Into Host Cell Manipulation by HIV
Richard Jefferys, Treatment Action Group; Posted Oct 13, 10:03 p.m. ET
Three recent study papers report the discovery of an important function of the HIV protein Nef, which give insight into another approach at combatting HIV.
Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.
Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?
Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?
Word on the Street: Why Are HIV Rates in the Latino Community So High?
David Duran, TheBody.com; Posted Oct 11, 4:13 p.m. ET
Why are HIV rates in the Latino community so high? Lack of culturally appropriate services? Family silence around sex? Or is it the scourge of stigma? We asked Latino people with HIV, advocates and professionals what they think is going on.
TeleHealth Empowers Rural Clinicians to Treat HIV, HCV Locally
Sony Salzman, TheBodyPRO.com; Posted Oct 9, 1:29 p.m. ET
In rural areas, scarce clinical resources exist for many people living with chronic infectious diseases -- or for the clinicians who provide care for them. But a program called Project ECHO is trying to turn that tide.
HIV Activists Storm Turing Pharmaceuticals Lobby and Demand Fair Pricing
Lucile Scott, TheBody.com; Posted Oct 9, 11:37 a.m. ET
"We wanted to call attention to the fact that this isn't just about one scummy hedge fund guy, but a whole bunch of them," explained Michael Kink of HedgeClippers. "Twenty of the 25 drugs with the fastest-rising prices over the past two years are linked to hedge funds."
WHO Calls for HIV Treatment for All and Massive PrEP Scale Up, to the Acclaim of Advocates
Jennifer Johnson Avril, TheBody.com; Posted Oct 9, 11:14 a.m. ET
The World Health Organization says all with HIV should start treatment as soon as they can, and anyone at high risk of HIV should have access to PrEP. Community reactions were swift and supportive -- with a dose of reality checking about what it'll take to make it so.
My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.
Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.
This Week in HIV Research: Genes That Shut Down HIV; Affordable Care Act Improves HIV Outcomes; Non-AIDS Cancer; and More
Warren Tong, TheBodyPRO.com; Posted Oct 9, 8:55 a.m. ET
This week we read about a pair of proteins that can shut down HIV's ability to infect cells. Meanwhile, a 30-year study finds higher rates of non-AIDS cancer among men who are living with HIV than those who are not.
HIV Treatment as Prevention: Can Acute Infections Shake Our Faith?
Sony Salzman, TheBodyPRO.com; Posted Oct 8, 11:45 p.m. ET
Treatment as prevention has become a bedrock concept in the quest to eradicate HIV. But Myron Cohen, M.D., asks, "How did we get to this belief?" And, as importantly, "Is there anything that could shake our faith?"
CDC: U.S. Hispanics/Latinos Three Times More Likely to Be Diagnosed With HIV Than Whites, With Rising Rates in Gay Men
Josh Kruger, TheBody.com; Posted Oct 8, 1:08 p.m. ET
CDC acknowledges that "much work still needs to be done" to reach Latinos. Elicia Gonzales of Philadelphia's GALAEI says that funding limited to testing and linkage to care puts HIV prevention work into a vacuum that neglects the needs of many.
What's Hot in HIV Clinical Science
Sony Salzman, TheBodyPRO.com; Posted Oct 8, 12:23 p.m. ET
What are the hottest developments in HIV clinical science over the past year? Physician-researcher Adaora Adimora, M.D., M.P.H., brought us a brief tour of key highlights at the start of the IDWeek 2015 medical conference in San Diego.
>> Browse Older Featured Stories